EZH2 Monoclonal Antibody
Applications
Predicted Reactivity
Overview | |
Catalog # | bsm-51468M |
Product Name | EZH2 Monoclonal Antibody |
Applications | WB, IHC-P, IF |
Predicted Reactivity | Human |
Specifications | |
Conjugation | Unconjugated |
Host | Mouse |
Source | Recombinant human EZH2. |
Clonality | Monoclonal |
Clone # | E3H5 |
Concentration | 0.5ug/ul |
Storage Buffer | 0.01M TBS(pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
Storage Condition | Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles. |
Target | |
Gene ID | 2146 |
Swiss Prot | Q15910 |
Subcellular location | Nucleus |
Synonyms | Enhancer of zeste homolog 2; Enx1h; MGC9169; Enhancer of zeste 2; ENX-1; ENX 1; ENX1; EZH 2; EZH2_HUMAN; Histone-lysine N-methyltransferase EZH2; KMT6A; Lysine N-methyltransferase 6; Enhancer of zeste homolog 2 (Drosophila); Enhancer of zeste, Drosophila, homolog 2; KMT 6;KMT6A; KMT6; WVS2. |
Background | Polycomb group (PcG) protein. Catalytic subunit of the PRC2/EED-EZH2 complex, which methylates 'Lys-9' (H3K9me) and 'Lys-27' (H3K27me) of histone H3, leading to transcriptional repression of the affected target gene. Able to mono-, di- and trimethylate 'Lys-27' of histone H3 to form H3K27me1, H3K27me2 and H3K27me3, respectively. Compared to EZH2-containing complexes, it is more abundant in embryonic stem cells and plays a major role in forming H3K27me3, which is required for embryonic stem cell identity and proper differentiation. The PRC2/EED-EZH2 complex may also serve as a recruiting platform for DNA methyltransferases, thereby linking two epigenetic repression systems. Genes repressed by the PRC2/EED-EZH2 complex include HOXC8, HOXA9, MYT1, CDKN2A and retinoic acid target genes. EZH2 can also methylate non-histone proteins such as the transcription factor GATA4. |
Application Dilution | |
WB | =1:500-2000,IHC-P=1:400-800,IF=1:100-500, |
IHC-P | 1:200-400 |
IF |